News & Updates

Water-free cyclosporine eye drops a promising treatment for dry eye disease
Water-free cyclosporine eye drops a promising treatment for dry eye disease
17 Mar 2024 byJairia Dela Cruz

Individuals with moderate-to-severe dry eye disease appear to obtain marked symptomatic improvements with a water-free cyclosporine 0.1% eye solution, according to the results of a phase III vehicle-controlled study from China.

Water-free cyclosporine eye drops a promising treatment for dry eye disease
17 Mar 2024
Broaden screening in patients with TB or HBV, says study
Broaden screening in patients with TB or HBV, says study
17 Mar 2024 byStephen Padilla

Patients with hepatitis B virus (HBV) infection are at heightened risk of latent tuberculosis (TB), while those with latent TB are also at increased risk of HBV infection, reveals a study. Notably, the risk of co-infection is highest among Asians and those born in high-incidence countries.

Broaden screening in patients with TB or HBV, says study
17 Mar 2024
When is the best time for kids to get flu vaccine?
When is the best time for kids to get flu vaccine?
16 Mar 2024 byStephen Padilla

Birth month is predictive of influenza vaccination timing in young children, owing to its impact on the scheduling of preventive care visits, reports a US study. Specifically, children born in October are more likely to be vaccinated in the same month and less likely to be diagnosed with influenza, supporting recommendations that promote October vaccination.

When is the best time for kids to get flu vaccine?
16 Mar 2024
DME predicts renal failure in diabetic patients with CKD
DME predicts renal failure in diabetic patients with CKD
15 Mar 2024

Patients with diabetes mellitus (DM) and chronic kidney disease (CKD) are at greater risk of end-stage renal disease (ESRD), dialysis, and renal transplantation at 5 years if they also have diabetic macular edema (DME), reveals a study.

DME predicts renal failure in diabetic patients with CKD
15 Mar 2024
Apremilast improves symptoms, QoL in patients with genital psoriasis
Apremilast improves symptoms, QoL in patients with genital psoriasis
15 Mar 2024 byStephen Padilla

Treatment with apremilast results in a significant reduction in genital psoriasis (G-PsO), as well as improvements in itch, pain, discomfort, redness, and quality of life (QoL), in patients with moderate-to-severe G-PsO who are intolerant to topical therapies, a study has shown.

Apremilast improves symptoms, QoL in patients with genital psoriasis
15 Mar 2024
Lockdown-induced inactivity may impair teens’ metabolic profile
Lockdown-induced inactivity may impair teens’ metabolic profile
15 Mar 2024

Forced sedentary behaviour, brought about by the COVID-19 lockdown, has negative effects on the metabolic and inflammatory profile of many teenagers, which can potentially lead to long-term poor health outcomes, suggests a study.

Lockdown-induced inactivity may impair teens’ metabolic profile
15 Mar 2024